Cited 0 times in
A double-blind, 4-block randomized, placebo-controlled, adaptive phase 2/3 trial to confirm efficacy of BLS-ILB-E710c in patients with cervical intraepithelial neoplasia 2/3 with extension study
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.